TAC1 and treatment resistant depression: These investigations included human brain imaging studies as well as research seeking to detect various biological markers or mechanisms involved in the experience of TRD (e.g., lower plasma levels of Coenzyme Q10 [20], lower cerebral spinal fluid levels of substance P [21], impaired glucocorticoid receptor function [22]).